Evidence map›Paper›PMID 41612209›Full record

ArticleBMC gastroenterology2026

Interpretable machine learning model for predicting 5-Year postoperative recurrence risk in patients with stage III colon cancer using preoperative laboratory tests: a two-centre study.

Hangping Wei, Xihao Fu, Yuanyuan Cheng, Li Xu, Xinkai Wu, ZhenXin Wang

Abstract readMulticenter Study
In one paragraph

Article in BMC gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hangping WeiDepartment of Medical Oncology, The First Affiliated Hospital of Soochow University, 899 Pinghai Road, Suzhou, Jiangsu, 215006, P.R. China.
Xihao FuDepartment of Medical Oncology, The First Affiliated Hospital of Soochow University, 899 Pinghai Road, Suzhou, Jiangsu, 215006, P.R. China.
Yuanyuan ChengDepartment of Medical Oncology, Dongyang Hospital Affiliated to Wenzhou Medical University, Dongyang, Zhejiang, 322100, P.R. China.
Li XuDepartment of Medical Oncology, Dongyang Hospital Affiliated to Wenzhou Medical University, Dongyang, Zhejiang, 322100, P.R. China.
Xinkai WuDepartment of Colorectal Medicine, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, Zhejiang, 310000, P.R. China.
ZhenXin WangDepartment of Medical Oncology, The First Affiliated Hospital of Soochow University, 899 Pinghai Road, Suzhou, Jiangsu, 215006, P.R. China. zhenxw316@163.com.

Funding

the Key Project of the Jinhua Science and Technology Bureau Grant No. 2024-3-115
6 · The paper itself

Abstract

backgroundColorectal cancer (CRC) is one of the most prevalent malignant diseases worldwide and displays significant heterogeneity. The aim of this study was to investigate the application of machine learning algorithms to incorporate preoperative laboratory tests for predicting the 5-year recurrence risk in patients with stage III colon cancer (CC) postsurgery.

methodsThis study included two patient cohorts: the Zhejiang Cancer Hospital CC cohort (ZCC set, n = 290), which served as the training cohort, and the Dongyang CC cohort (DYC set, n = 125), which was utilized as an external testing cohort. Univariate analysis was initially performed on the 48 preoperative laboratory tests and 15 clinical and pathological features within the training cohort to pinpoint potential predictors. Features with a p value less than 0.05 were incorporated, and six machine learning models-logistic regression, random forest, XGBoost, support vector machine (SVM), back propagation neural network (BP NET), and K-nearest neighbour (KNN)-were employed to develop a model for predicting the 5-year recurrence risk in patients with stage III colon cancer. The prediction efficacy was assessed by calculating the area under the curve (AUC) of the machine learning model using the external test dataset, and comparisons were performed via the DeLong test. Ultimately, the Shapley additive explanations (SHAP) algorithm was applied to rank feature importance and compute the SHAP values for each feature, which were then visualized.

resultsUnivariate analysis identified 10 laboratory tests and 6 clinical and pathological features that were incorporated into six machine learning models. The random forest model exhibited the highest predictive performance in the test cohort, with an AUC of 0.845. Logistic regression closely trailed, achieving an AUC of 0.823. The DeLong test revealed that the predictive performance of the random forest model was comparable to that of logistic regression and outperformed the other models. SHAP analysis indicated that the most important feature for predicting the 5-year recurrence risk of stage III colon cancer was perineural invasion, followed by FIB and then PT.

conclusionsA machine learning model constructed using preoperative laboratory tests and clinical and pathological features can assist in predicting the 5-year recurrence risk of patients with stage III colon cancer. This model provides potential reference values for the clinical development of individualized treatment strategies.

Indexed as

Colonic NeoplasmsMachine LearningNeoplasm Recurrence, LocalAgedArea Under CurveFemaleHumansLogistic ModelsMaleMiddle AgedNeoplasm StagingNeural Networks, ComputerPredictive Value of TestsRisk AssessmentCancer recurrenceColon cancerLaboratory testMachine learning modelStage III

Identifiers

PMID41612209
PMCPMC12857113

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.